Association of Diagnostic Stewardship for Blood Cultures in Critically Ill Children With Culture Rates, Antibiotic Use, and Patient Outcomes: Results of the Bright STAR Collaborative.

Importance Blood culture overuse in the pediatric intensive care unit (PICU) can lead to unnecessary antibiotic use and contribute to antibiotic resistance. Optimizing blood culture practices through diagnostic stewardship may reduce unnecessary blood cultures and antibiotics. Objective To evaluate the association of a 14-site multidisciplinary PICU blood culture collaborative with culture rates, antibiotic use, and patient outcomes. Design, Setting, and Participants This prospective quality improvement (QI) collaborative involved 14 PICUs across the United States from 2017 to 2020 for the Bright STAR (Testing Stewardship for Antibiotic Reduction) collaborative. Data were collected from each participating PICU and from the Children's Hospital Association Pediatric Health Information System for prespecified primary and secondary outcomes. Exposures A local QI program focusing on blood culture practices in the PICU (facilitated by a larger QI collaborative). Main Outcomes and Measures The primary outcome was blood culture rates (per 1000 patient-days/mo). Secondary outcomes included broad-spectrum antibiotic use (total days of therapy and new initiations of broad-spectrum antibiotics ≥3 days after PICU admission) and PICU rates of central line-associated bloodstream infection (CLABSI), Clostridioides difficile infection, mortality, readmission, length of stay, sepsis, and severe sepsis/septic shock. Results Across the 14 PICUs, the blood culture rate was 149.4 per 1000 patient-days/mo preimplementation and 100.5 per 1000 patient-days/mo postimplementation, for a 33% relative reduction (95% CI, 26%-39%). Comparing the periods before and after implementation, the rate of broad-spectrum antibiotic use decreased from 506 days to 440 days per 1000 patient-days/mo, respectively, a 13% relative reduction (95% CI, 7%-19%). The broad-spectrum antibiotic initiation rate decreased from 58.1 to 53.6 initiations/1000 patient-days/mo, an 8% relative reduction (95% CI, 4%-11%). Rates of CLABSI decreased from 1.8 to 1.1 per 1000 central venous line days/mo, a 36% relative reduction (95% CI, 20%-49%). Mortality, length of stay, readmission, sepsis, and severe sepsis/septic shock were similar before and after implementation. Conclusions and Relevance Multidisciplinary diagnostic stewardship interventions can reduce blood culture and antibiotic use in the PICU. Future work will determine optimal strategies for wider-scale dissemination of diagnostic stewardship in this setting while monitoring patient safety and balancing measures.

[1]  Katherine E. M. Hoops,et al.  Diagnostic Stewardship of Endotracheal Aspirate Cultures in a PICU , 2021, Pediatrics.

[2]  J. Klatte,et al.  Pediatric Antimicrobial Stewardship Programs: Current Perspectives , 2020, Pediatric health, medicine and therapeutics.

[3]  Christopher P. Bonafide,et al.  Practices, Perceptions, and Attitudes in the Evaluation of Critically Ill Children for Bacteremia: A National Survey* , 2019, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[4]  M. Weinstein,et al.  Practical Guidance for Clinical Microbiology Laboratories: A Comprehensive Update on the Problem of Blood Culture Contamination and a Discussion of Methods for Addressing the Problem , 2019, Clinical Microbiology Reviews.

[5]  Nila Suntharam,et al.  Optimizing testing for Clostridium difficile infection: A quality improvement project , 2019, American journal of infection control.

[6]  Sybil A. Klaus,et al.  Association of a blood culture utilization intervention on antibiotic use in a pediatric intensive care unit , 2019, Infection Control & Hospital Epidemiology.

[7]  G. Garber,et al.  Reducing unnecessary urine culturing and antibiotic overprescribing in long-term care: a before-and-after analysis. , 2019, CMAJ open.

[8]  James C. Fackler,et al.  Dissemination of a Novel Framework to Improve Blood Culture Use in Pediatric Critical Care , 2018, Pediatric quality & safety.

[9]  A. Pakyz,et al.  Pediatric Antimicrobial Stewardship: State of the Art , 2018, Current Infectious Disease Reports.

[10]  Wendy Levinson,et al.  Choosing Wisely Campaigns: A Work in Progress , 2018, JAMA.

[11]  Joshua D. Courter,et al.  Accuracy of Administrative Data for Antimicrobial Administration in Hospitalized Children , 2017, Journal of the Pediatric Infectious Diseases Society.

[12]  S. Brownlee,et al.  Evidence for overuse of medical services around the world , 2017, The Lancet.

[13]  T. Bell,et al.  Validation of antibiotic charges in administrative data for outpatient pediatric urologic procedures. , 2017, Journal of Pediatric Urology.

[14]  Cynthia Y. Truong,et al.  Real-Time Electronic Tracking of Diarrheal Episodes and Laxative Therapy Enables Verification of Clostridium difficile Clinical Testing Criteria and Reduction of Clostridium difficile Infection Rates , 2017, Journal of Clinical Microbiology.

[15]  Elizabeth Colantuoni,et al.  Association of a Clinical Practice Guideline With Blood Culture Use in Critically Ill Children , 2017, JAMA pediatrics.

[16]  Rachael K Ross,et al.  Value of Procalcitonin Measurement for Early Evidence of Severe Bacterial Infections in the Pediatric Intensive Care Unit. , 2016, The Journal of pediatrics.

[17]  E. Kaiser,et al.  A Multifaceted Approach to Reduction of Catheter-Associated Urinary Tract Infections in the Intensive Care Unit With an Emphasis on “Stewardship of Culturing” , 2016, Infection Control & Hospital Epidemiology.

[18]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[19]  L. Epstein,et al.  Evaluation of a Novel Intervention to Reduce Unnecessary Urine Cultures in Intensive Care Units at a Tertiary Care Hospital in Maryland, 2011–2014 , 2016, Infection Control & Hospital Epidemiology.

[20]  J. Bouyer,et al.  Use of Procalcitonin Assays to Predict Serious Bacterial Infection in Young Febrile Infants. , 2016, JAMA pediatrics.

[21]  F. Davidoff,et al.  SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence) , 2015, Journal of Nursing Care Quality.

[22]  Y. Vergouwe,et al.  C-Reactive Protein Bedside Testing in Febrile Children Lowers Length of Stay at the Emergency Department , 2015, Pediatric emergency care.

[23]  S. Brownlee,et al.  Setting a research agenda for medical overuse , 2015, BMJ : British Medical Journal.

[24]  Derek Wheeler,et al.  Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. , 2015, American journal of respiratory and critical care medicine.

[25]  V. Nadkarni,et al.  Delayed Antimicrobial Therapy Increases Mortality and Organ Dysfunction Duration in Pediatric Sepsis* , 2014, Critical care medicine.

[26]  Brian Reid,et al.  Overdiagnosis and overtreatment in cancer: an opportunity for improvement. , 2013, JAMA.

[27]  Herman Goossens,et al.  The Antibiotic Resistance and Prescribing in European Children Project: A Neonatal and Pediatric Antimicrobial Web-based Point Prevalence Survey in 73 Hospitals Worldwide , 2013, The Pediatric infectious disease journal.

[28]  D. Berwick,et al.  Eliminating waste in US health care. , 2012, JAMA.

[29]  Jeffrey S Gerber,et al.  Variability in Antibiotic Use at Children's Hospitals , 2010, Pediatrics.

[30]  D. Cornfield,et al.  Utility of blood cultures in postoperative pediatric intensive care unit patients* , 2009, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[31]  M. Baker,et al.  Fever in the new millennium: a review of recent studies of markers of serious bacterial infection in febrile children , 2005, Current opinion in pediatrics.

[32]  David Wennberg,et al.  The Implications of Regional Variations in Medicare Spending. Part 2: Health Outcomes and Satisfaction with Care , 2003, Annals of Internal Medicine.

[33]  M. Chassin,et al.  The urgent need to improve health care quality. Institute of Medicine National Roundtable on Health Care Quality. , 1998, JAMA.

[34]  M. Saul,et al.  Utilization and diagnostic yield of blood cultures in a surgical intensive care unit. , 1997, Critical care medicine.

[35]  L Goldman,et al.  Contaminant blood cultures and resource utilization. The true consequences of false-positive results. , 1991, JAMA.